v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net income (loss) $ 1,365 $ (25,915)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 164,313 140,636
Depreciation for early lease purchase options (buyouts) 37,671 29,061
Depreciation for impaired leases 28,652 24,962
Change in fair value of derivative liability, warrants, and other (17,381) (256)
Stock-based compensation 3,693 5,759
Gain on extinguishment of term loan and settlement of derivative liability, net (5,120) 0
Amortization of debt discount 3,002 3,104
Amortization of debt issuance costs, net 2,410 220
Accrued PIK interest expense 3,291 1,440
Amortization of right-of-use assets 183 318
Changes in operating assets and liabilities:    
Property held for lease (236,014) (201,189)
Prepaid expenses and other current assets 2,288 (2,053)
Litigation insurance reimbursement receivable 0 5,000
Accounts payable 400 588
Accrued liabilities 129 (6,775)
Accrued litigation (695) (7,055)
Lease liabilities (180) (288)
Unearned revenues 60 (126)
Net cash used in operating activities (11,933) (32,569)
Cash flows from investing activities:    
Purchases of property and equipment (34) (54)
Additions to capitalized software (1,147) (1,249)
Other assets and security deposits 76 0
Net cash used in investing activities (1,105) (1,303)
Cash flows from financing activities:    
Proceeds from New and Existing Revolving Facilities 21,968 34,421
Principal repayments on New and Existing Revolving Facilities (25,999) (12,406)
Repayment of term loan and repurchase of warrants (35,070) 0
Payments of issuance costs related to debt and preferred stock (5,347) 0
Repurchases of restricted stock (594) (613)
Proceeds from issuance of Convertible Preferred Stock and warrants 65,000 0
Proceeds from exercise of stock options 8 211
Net cash provided by financing activities 19,966 21,613
Net increase (decrease) in cash, cash equivalents and restricted cash 6,928 (12,259)
Cash, cash equivalents and restricted cash at beginning of period 16,552 28,811
Cash, cash equivalents and restricted cash at end of period 23,480 16,552
Supplemental disclosure of cash flow information:    
Cash paid for interest 11,693 13,709
Cash paid for income taxes 106 226
Cash paid for operating leases 275 359
Supplemental disclosure of non-cash investing and financing activities    
Issuance of warrants to purchase common stock in connection with debt refinancing 3,934 0
Issuance of common stock in connection with litigation settlements 1,505 1,756
Issuance of New Term Loan derivative liability in connection with debt refinancing 3,558 0
Debt issuance costs accrued but not yet paid 200 0
Extinguishment of Existing Term Loan $ 32,654 $ 0